Nordic Life Science Days’ Post

Thanks Medicon Village, Sarah Lidé also from VILDA - Ledande kvinnor i Life Science and Petter Magnusson Hartman and team - all acting as real Life Science Ambassadors- for taking the pulse in Skåne! In this issue focusing on Skåne Life Science I got the opportunity to reflect on Gender balance in top management and boards. It’s a fact that gender diversity leads to improved competitiveness. Creating a culture of inclusion and leveraging diverse perspectives to drive success. Companies that do not grasp this risk stagnation and decreased competitiveness. They will become the losers. By prioritizing diversity, the life science sector can strengthen its competitiveness and ensure its long-term sustainability! Time to act - through clear communication and education! Engage the younger generation to ensure a sound a future! #ClosingTheGenderGap #Diversity #FemaleLeadership #LifeScience

What is the sentiment among life science companies in Skåne, and how are they positioned for the future? Our newly launched report, “Life Science Barometer 2024 – Skåne Edition”, aims to address these questions and more, complementing facts and figures on the life science sector in Skåne with thematic interviews featuring Carl Borrebaeck, Anna Gisselsson, Christina Östberg Lloyd and Søren Bregenholt discussing topics such as growing competitive life science companies, funding, diversity in leadership, and how companies should navigate the coming year.   Some key highlights from the report: * There are about 820 companies and organisations active within the life science sector in Skåne, of which more than 560 are classified under the core life science segments of pharma, biotech, medtech and diagnostics. * Micro-sized companies dominate the company composition in Skåne – they represent 83 % of all life science companies. Medtech is also the biggest segment in Skåne, representing 43 % of life science companies. * Skåne punches above its weight within biopharma – life science companies based in the region contribute to 27 % of the Swedish drug pipeline. * Finding and securing funding is a critical area of focus among Skåne respondents in the short term, while in the longer term, Skåne respondents are focused on market growth, and recruitment and development for both the workforce as well as company leadership.   The Skåne report is produced by Medicon Village and supported by Sparbanken Skåne. It builds on the findings from the national Life Science Barometer 2024 report produced by SwedenBIO as well as statistics from STUNS Life Science’s Insight Machine.   To download the report: https://lnkd.in/dKYNUSv8 #facts #lifescience #sciencepark STUNS Life science | Region Skåne – utveckling & innovation | Region Skåne | Skånes universitetssjukhus (Skåne University Hospital) | Lif - de forskande läkemedelsföretagen | Lunds universitet | | Medicinska fakulteten, Lunds universitet | Malmö universitet | Lunds kommun | Ideon Science Park | Medeon Science Park & Incubator | Medicon Valley Alliance

During my time at Helix Biogen Institute, I had the privilege of connecting and learning from an exceptional team, including staff members and Dr. Oladipo Elijah Kolawole (Ph.D).These meaningful interactions significantly broadened my knowledge and deepened my understanding of biomedical research.Through these connections, I gained valuable insights into research methodologies, expert perspectives on industry trends and challenges, enhanced understanding of interdisciplinary collaborations, exposure to innovative problem-solving approaches, mentorship and guidance from experienced professionals. Day 12 of 30 #HelixBiogenInstituteChallenge #ScientificChallenge #Bioinformatics #Healthcare #Challenge #HelixBiogenInstitute

Innovation in Queensland’s Biomedical industry sector is expected to multiply in the near future with the growing demand for targeted therapies.   Good thing Queensland’s biomedical sector is thriving 🤩   Queensland’s innovation pipeline and biomedical ecosystem is encouraging innovative bio-based start-ups, investors, and researchers to maximise the opportunities created by the growing global bioeconomy.   The state is home to a network of world class key biomedical research and manufacturing precincts and over 130 research organisations involved in biomedical research and development.   Next week Queensland Treasury, Queensland Health and Department of State Development and Infrastructure will represent the Queensland Government with Life Sciences Queensland Ltd (LSQ) and Trade and Investment Queensland at AusBiotech 2024 in Melbourne to meet with industry and talk more about Queensland’s exciting biotech future. #Qldbiotech #AusBio24 #Biomedical | Image courtesy of WearOptimo.

🌎 #Biocat leads a mission to Boston to strengthen #BioRegionCatalonia ties with this leading region in healthcare innovation in the United States. Some key highlights: ✔ The participation in the World Medical Innovation Forum, the top event in the Boston innovation ecosystem. With 2.000 industry leaders, including C-level executives and heads of research institutions. ✔ Established connections with the Massachusetts General Brigham MESH Incubator and Novartis Institutes for BioMedical Research to discuss collaborative opportunities in clinical research and advanced therapies. The mission featured representatives from 12 key institutions in the BioRegion, members of the Advanced Therapies Network of Catalonia, including: Germans Trias i Pujol Research Institute (IGTP), Institut de Recerca Sant Pau, Institute for Bioengineering of Catalonia (IBEC), Leitat Technological Center, Barcelona Institute of Science and Technology (BIST) and the companies MiMark diagnostics, Reig Jofre and Farmhispania Group. Biocat CEO Robert Fabregat Fuentes and Strategic Foresight and International Relations Director Montse Daban Marín attended on behalf of the organization. The mission was organized by #Biocat with the Catalan Ministry for European Union and Foreign Action, Catalan Ministry of Health and Catalan Ministry of Research and Universities. https://lnkd.in/dZwdy7Ne

We're excited to share our latest case study in collaboration with Invest Aberdeen, highlighting Aberdeen's growing life sciences sector. A recent Life Science summit hosted by The Times and The Sunday Times, in Aberdeen, is a reminder of the regional strength in this sector. Aberdeen, a city undergoing a transformative journey to become the energy capital of Europe, now also has gained recognition in life sciences. Why Aberdeen? ⬇️ Strong Regional Clusters: The city is home to notable biotech spinouts, startups, and respected institutes. Education: With institutions like the University of Aberdeen and Robert Gordon University Aberdeen produces some of Scotland’s most employable graduates. Innovative Ecosystem: Facilities like the Scottish Biologics, ONE BioHub (ONE Life Sciences) and the The James Hutton Institute drive cutting-edge research and commercial applications. Success Stories ⬇️ NovaBiotics Ltd: An innovative biotech group making strides in consumer health and pharmaceuticals. Vertebrate Antibodies: Enhancing lives through high-quality antibody development. Sirakoss: A medical technology start-up acquired by OssDsign, showcasing international commercial appeal. Aberdeen is not just leading in energy but also setting new benchmarks in life sciences innovation. This case study delves into the dynamic ecosystem of start ups, research facilities, and academic institutions that make Aberdeen a prime location for investment and collaboration. Read the full case study here 🔗https://lnkd.in/gNWwAS9K

The power of partnerships!

Order your 'Global Life Science Tools Market - Forecasts to 2029' FREE Sample Report via https://lnkd.in/dgwxUX6m The life science tools market is on a remarkable growth trajectory, and by 2029, several regions are expected to dominate this dynamic landscape. Here’s a closer look at the key regions poised to lead the market and the factors driving their growth: 1. North America 🇺🇸🇨🇦 North America is set to remain a major player in the life science tools market. The region's growth is driven by: Robust R&D Infrastructure: Leading universities, research institutions, and biotech companies are continuously pushing the envelope in innovation. Government Funding: Significant investments in healthcare and life sciences by federal and state governments. 2. Europe Europe is another key region expected to see substantial growth, driven by: Innovative Research Hubs: Countries like Germany, the UK, and Switzerland are home to top-notch research facilities. Collaborative Ecosystem: Strong collaborations between academia, industry, and government initiatives. Regulatory Support: Favorable regulatory frameworks that support life sciences research and development. 3. Asia-Pacific Asia-Pacific is rapidly emerging as a leading region due to: Increasing Healthcare Investments: Significant investments in healthcare infrastructure and research capabilities, especially in China and India. Growing Biotechnology Sector: A booming biotech industry, with many startups and established companies driving innovation. Expanding Markets: Rising demand for advanced medical tools and diagnostics, fueled by a growing population and increased health awareness. 4. Latin America Latin America, particularly Brazil and Mexico, is also expected to experience growth: Improving Healthcare Infrastructure: Investments in healthcare and research infrastructure are on the rise. Growing Biotech Industry: An expanding biotech sector that’s driving demand for advanced life science tools. Government Initiatives: Supportive government policies promoting research and development in life sciences. Each of these regions has its unique strengths and contributions, but together they are shaping a vibrant future for the life science tools market. The next decade will undoubtedly bring groundbreaking advancements as these regions continue to lead the charge. What trends do you see influencing this market? Share your insights in the comments! BD Agilent Technologies Illumina Thermo Fisher Scientific F. Hoffmann-La Roche Ltd Bio-Rad Laboratories Merck Group GE HealthCare Bruker QIAGEN #GlobalLifeScienceToolsMarketMarket #GlobalMarketEstimates #GME #LifeScienceTools #HealthcareInnovation #GlobalMarket #NorthAmerica #Europe #AsiaPacific #LatinAmerica #Biotech #ResearchAndDevelopment #MarketGrowth #HealthcareIndustry

14 years ago, we embarked on a journey born from our own struggles in building biotech companies. Our mission? To change how biotechs are built and empower innovation worldwide. Today, we're grateful to share our first Impact Report. Here are some highlights and impressive numbers on what we and our community achieved: - 320+ resident companies supported in 2023 - each with a unique vision - $650M+ raised, fueling the next generation of scientific breakthroughs - 21 clinical trials bringing hope to patients worldwide - 2,358 patients enrolled, courageously participating in cutting-edge research But numbers only tell part of the story. Behind each statistic is a team of dedicated scientists working tirelessly in our labs, a patient awaiting a life-changing treatment, and a future where diseases once thought incurable become manageable or even curable. We invite you to read our full report: https://lnkd.in/emKWM67Y We express our gratitude to our great teams around the globe for supporting our residents and helping them thrive: BioLabs Greater Boston, BioLabs Philadelphia, Biolabs@NYULangone, BioLabs Pegasus Park - North Texas, BioLabs North Carolina, BioLabs New Haven, BioLabs San Diego, BioLabs at The Lundquist Institute, Princeton Innovation Center BioLabs, BioLabs France, BioLabs Heidelberg, iCONM in collaboration with BioLabs Share your thoughts on BioLabs' impact! Have you or someone you know benefited from biotech innovations? What excites you most about the future of life sciences? Let's discuss how we can further empower scientific breakthroughs. #BioLabsImpact #LifeScience #Biotechnology #EmpoweringInnovationWorldwide #StartupSuccess

Just one week to go until the Life Sciences Summit! If you are attending and are interested in advancing your life sciences research with #bioinformatics, arrange to meet with Eleanore Irvine or Tom Ng at the summit! Just send them a message on LinkedIn today and they will see you next week! #lifesciences #biotech #drugdiscovery